Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?

2016 ◽  
Vol 36 ◽  
pp. e387-e398 ◽  
Author(s):  
Jennifer R. Brown ◽  
Michael J. Hallek ◽  
John M. Pagel
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Lymphocytic Leukemia ◽  
Targeted Treatment

scholarly journals CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia

2018 ◽  
Vol 14 (6) ◽  
pp. 499-513 ◽  
Author(s):  
Paula Cramer ◽  
Julia von Tresckow ◽  
Jasmin Bahlo ◽  
Anja Engelke ◽  
Petra Langerbeins ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Minimal Residual Disease ◽  
Phase Ii ◽  
Residual Disease ◽  
Lymphocytic Leukemia ◽  
Targeted Treatment ◽  
Phase Ii Trials ◽  
Minimal Residual

scholarly journals Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib

2021 ◽  
Vol Volume 14 ◽  
pp. 5507-5519
Author(s):  
Candida Vitale ◽  
Jamie Lynn Gibbons ◽  
Alessandra Ferrajoli
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Clinical Utility ◽  
Lymphocytic Leukemia ◽  
Targeted Treatment
Sign in / Sign up

Export Citation Format

Share Document